diabetic nephropathy

Sweet Pee: Do SGLT2 Inhibitors Prevent and/or Slow the Progression of Diabetic Kidney Disease?

August 15, 2018 // 1 Comment

During NephMadness 2017, the newcomer ‘SGLT2 inhibitors’ team for the Diabetic Nephropathy region surprised the competition and made it all the way to the Filtered Four [...]

Creatinine Linearity – Connecting the Dots Has Never Been So Complicated

December 8, 2017 // 0 Comments

Prediction. My least favorite part of the chronic kidney disease (CKD) clinic visit. “No crystal ball.” “I’m not in a position to guess.” “Only God knows the [...]

#NephMadness 2017: Can the Reigning Champions, RAAS inhibitors, be Dethroned?

March 23, 2017 // 0 Comments

Vecihi Batuman Dr. Batuman, MD, is Professor of Medicine at Tulane University Medical School, and Chief of Nephrology at the New Orleans VA Medical Center. His research [...]

#NephMadness 2017: Diabetic Nephropathy Region

March 7, 2017 // 2 Comments

Submit your picks | NephMadness 2017 | #NephMadness or #DNRegion Selection Committee Member for the Diabetic Nephropathy Region: Anna Burgner Dr. Burgner, MD, MEHP, is an [...]

#KidneyWk 2015: Not Just VEGF: Diabetes and the Endothelium

November 10, 2015 // 0 Comments

Diabetes and Diabetic Nephropathy (DN) were appropriately prominent topics at this year’s meeting. Thursday’s afternoon session, “Glomerular Endothelial Cell Injury [...]

AJKD Blog

Official Blog of the American Journal of Kidney Diseases